Cargando…

Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012

Detalles Bibliográficos
Autores principales: Knörr, Fabian, Zimmermann, Martin, Attarbaschi, Andishe, Kabíčková, Edita, Maecker-Kolhoff, Britta, Ruf, Stephanie, Kühnle, Ingrid, Ebinger, Martin, Garthe, Anne-Kathrin, Simonitsch-Klupp, Ingrid, Oschlies, Ilske, Klapper, Wolfram, Burkhardt, Birgit, Woessmann, Wilhelm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634171/
https://www.ncbi.nlm.nih.gov/pubmed/34498443
http://dx.doi.org/10.3324/haematol.2021.278971
_version_ 1784608082680086528
author Knörr, Fabian
Zimmermann, Martin
Attarbaschi, Andishe
Kabíčková, Edita
Maecker-Kolhoff, Britta
Ruf, Stephanie
Kühnle, Ingrid
Ebinger, Martin
Garthe, Anne-Kathrin
Simonitsch-Klupp, Ingrid
Oschlies, Ilske
Klapper, Wolfram
Burkhardt, Birgit
Woessmann, Wilhelm
author_facet Knörr, Fabian
Zimmermann, Martin
Attarbaschi, Andishe
Kabíčková, Edita
Maecker-Kolhoff, Britta
Ruf, Stephanie
Kühnle, Ingrid
Ebinger, Martin
Garthe, Anne-Kathrin
Simonitsch-Klupp, Ingrid
Oschlies, Ilske
Klapper, Wolfram
Burkhardt, Birgit
Woessmann, Wilhelm
author_sort Knörr, Fabian
collection PubMed
description
format Online
Article
Text
id pubmed-8634171
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-86341712021-12-17 Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012 Knörr, Fabian Zimmermann, Martin Attarbaschi, Andishe Kabíčková, Edita Maecker-Kolhoff, Britta Ruf, Stephanie Kühnle, Ingrid Ebinger, Martin Garthe, Anne-Kathrin Simonitsch-Klupp, Ingrid Oschlies, Ilske Klapper, Wolfram Burkhardt, Birgit Woessmann, Wilhelm Haematologica Letters to the Editor Fondazione Ferrata Storti 2021-09-09 /pmc/articles/PMC8634171/ /pubmed/34498443 http://dx.doi.org/10.3324/haematol.2021.278971 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Letters to the Editor
Knörr, Fabian
Zimmermann, Martin
Attarbaschi, Andishe
Kabíčková, Edita
Maecker-Kolhoff, Britta
Ruf, Stephanie
Kühnle, Ingrid
Ebinger, Martin
Garthe, Anne-Kathrin
Simonitsch-Klupp, Ingrid
Oschlies, Ilske
Klapper, Wolfram
Burkhardt, Birgit
Woessmann, Wilhelm
Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012
title Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012
title_full Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012
title_fullStr Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012
title_full_unstemmed Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012
title_short Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012
title_sort dose-adjusted epoch-rituximab or intensified b-non-hodgkin lymphoma therapy for pediatric primary mediastinal large b-cell lymphoma. results from the study b-nhl-bfm-04 and the nhl-bfm registry 2012
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634171/
https://www.ncbi.nlm.nih.gov/pubmed/34498443
http://dx.doi.org/10.3324/haematol.2021.278971
work_keys_str_mv AT knorrfabian doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012
AT zimmermannmartin doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012
AT attarbaschiandishe doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012
AT kabickovaedita doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012
AT maeckerkolhoffbritta doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012
AT rufstephanie doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012
AT kuhnleingrid doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012
AT ebingermartin doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012
AT gartheannekathrin doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012
AT simonitschkluppingrid doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012
AT oschliesilske doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012
AT klapperwolfram doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012
AT burkhardtbirgit doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012
AT woessmannwilhelm doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012